WELLINGTON MANAGEMENT GROUP LLP - ENTRADA THERAPEUTICS INC ownership

ENTRADA THERAPEUTICS INC's ticker is and the CUSIP is 29384C108. A total of 34 filers reported holding ENTRADA THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 1.6%.

Quarter-by-quarter ownership
WELLINGTON MANAGEMENT GROUP LLP ownership history of ENTRADA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$16,521,301
+7.0%
1,045,652
+2.6%
0.00%0.0%
Q2 2023$15,435,351
+4.9%
1,019,508
+0.5%
0.00%0.0%
Q1 2023$14,709,569
+7.7%
1,014,453
+0.4%
0.00%0.0%
Q4 2022$13,659,946
-13.9%
1,010,351
+0.3%
0.00%0.0%
Q3 2022$15,874,000
-15.1%
1,007,246
-34.4%
0.00%
-25.0%
Q2 2022$18,707,000
-21.5%
1,535,883
-39.6%
0.00%0.0%
Q1 2022$23,816,000
-54.9%
2,543,102
-18.3%
0.00%
-50.0%
Q4 2021$52,797,0003,114,0060.01%
Other shareholders
ENTRADA THERAPEUTICS INC shareholders Q3 2022
NameSharesValueWeighting ↓
72 Investment Holdings, LLC 509,023$7,706,60860.04%
MPM ASSET MANAGEMENT LLC 4,425,784$67,006,37032.86%
5AM Venture Management, LLC 4,408,379$66,742,85816.63%
StepStone Group LP 761,277$11,525,7342.13%
TCG Crossover Management, LLC 584,955$8,856,2191.45%
Redmile Group, LLC 1,311,572$19,857,2000.76%
Nan Fung Group Holdings Ltd 49,082$743,1010.48%
Baker Brothers Advisors 4,865,819$73,668,5000.43%
Corton Capital Inc. 18,067$273,5340.13%
MOORE CAPITAL MANAGEMENT, LP 105,000$1,589,7000.03%
View complete list of ENTRADA THERAPEUTICS INC shareholders